Advisory Research’s Omnicell OMCL Stock Holding History

Advisory Research’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,621	Closed	-$412K	–	391
2022 Q2	$412K	Buy	+3,621	New	+$416K	0.04%	249
2022 Q1	–	Sell	-7,504	Closed	-$1.35M	–	426
2021 Q4	$1.35M	Sell	7,504 -312	-4%	-$54.1K	0.11%	167
2021 Q3	$1.16M	Sell	7,816 -733	-9%	-$112K	0.07%	181
2021 Q2	$1.29M	Buy	8,549 +2,774	+48%	+$386K	0.09%	183
2021 Q1	$750K	Buy	+5,775	New	+$741K	0.05%	230
2018 Q1	–	Sell	-34,485	Closed	-$1.67M	–	410
2017 Q4	$1.67M	Buy	34,485 +1,867	+6%	+$94.2K	0.03%	234
2017 Q3	$1.67M	Sell	32,618 -3,672	-10%	-$176K	0.03%	235
2017 Q2	$1.56M	Buy	+36,290	New	+$1.51M	0.02%	258

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Advisory Research's OMCL Position: Q3 2022 in Review

Advisory Research sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 3,621 shares — an estimated $412K sold.

Advisory Research first reported a position in OMCL in Q2 2017 and held it in 8 quarters. The position peaked at $1.67M in Q4 2017. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

Advisory Research reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
Advisory Research sold 3,621 Omnicell shares in Q3 2022, an estimated $412K.
Advisory Research first reported a position in Omnicell in Q2 2017 and held it in 8 quarters.
Advisory Research's Omnicell position peaked at $1.67M in Q4 2017.
374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on Advisory Research's 13F filing for Q3 2022, filed 15 Nov 2022.